sodium benzoate/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases reduced glutathione concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“As a result, six-week treatment of sodium benzoate was linked to increased GSH levels than placebo.”
Quoted verbatim from Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial.. - Study
- RCT
- Duration
- 6 weeks
- Population
- Patients with clozapine-resistant schizophrenia on add-on treatment; plasma GSH, baseline to endpoint
Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial.2026PMID:41401723Permalink
Keep reading
- Everything the graph holds on sodium benzoate
- Every compound studied against Reduced glutathione concentration
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45K11G227P4G3M5KVQTH26F